EVEROLIMUS 0.25 MG TABLET

Everolimus tablets
$2.1478per EA

Strength

.25 mg/1

NDC

51991037906

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

EVEROLIMUS

Approval Type

Generic (ANDA)

FDA Application

ANDA205432

On Market Since

5/21/2021

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Decreased Immunologic Activity
Kinase Inhibitor
Protein Kinase Inhibitors
mTOR Inhibitor Immunosuppressant
mTOR Inhibitors

Price History

1W

0.0%

1M

-6.2%

3M

-7.9%

6M

-4.2%

1Y

+0.9%

3Y

N/A

5Y

N/A

All

-32.6%